| scholarly article | Q13442814 |
| P2093 | author name string | J Albert | |
| G Biberfeld | |||
| B Böttiger | |||
| P Putkonen | |||
| R Thorstensson | |||
| K Warstedt | |||
| P433 | issue | 4 | |
| P921 | main subject | experimental infection | Q107184421 |
| crab-eating macaque | Q301676 | ||
| P304 | page(s) | 366-373 | |
| P577 | publication date | 1989-01-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2 | |
| P478 | volume | 2 |
| Q30789664 | A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection |
| Q33240079 | Analysis of 10,000 ESTs from lymphocytes of the cynomolgus monkey to improve our understanding of its immune system |
| Q40487963 | Antiviral therapy in human immunodeficiency virus infections. Current status (Part II). |
| Q36698091 | Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates |
| Q40040768 | Evolution of the human immunodeficiency virus type 2 envelope gene in preimmunized and persistently infected rhesus macaques |
| Q72104090 | Generation, characterization and cross-reactivities of monoclonal antibodies against the p24 core protein and the gp130 envelope glycoprotein of HIV-2ben |
| Q33784708 | Genetic variation in a human immunodeficiency virus type 2 live-virus Macaca nemestrina vaccine model |
| Q93104023 | HIV-2 as a model to identify a functional HIV cure |
| Q37546827 | Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity |
| Q42018824 | Immunization with Tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection |
| Q33395672 | Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV |
| Q36699146 | In vivo genetic variability of the human immunodeficiency virus type 2 V3 region |
| Q35812189 | Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus |
| Q35839457 | Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120 |
| Q33745137 | Penetration of zidovudine and 3'-fluoro-3'-deoxythymidine into the brain, muscle tissue, and veins in cynomolgus monkeys: relation to antiviral action |
| Q44075272 | Persistent infection of baboons and Rhesus monkeys with different strains of HIV-2 |
| Q36783146 | Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects |
| Q40191155 | Tackling HIV and AIDS: contributions by non-human primate models |
| Q36632917 | Variability of the env gene in cynomolgus macaques persistently infected with human immunodeficiency virus type 2 strain ben. |
Search more.